Ceribell │ AI-Powered Point-of-Care EEG

Ceribell, Inc., the developer of the first AI-powered point-of-care EEG diagnostic system, is revolutionizing seizure management in acute care. Ceribell’ mission is to make EEG diagnostics widely available, more efficient, and more cost-effective, to improve the detection and treatment of neurological conditions.

The Ceribell system provides rapid access to accurate diagnostic information and continuous monitoring at the bedside 24/7, enabling precise patient care and hospital-wide efficiencies. The Ceribell system first received FDA 510(k) clearance in 2017 and is commercially available in the United States. The latest ClarityPro AI algorithm is the first and only FDA-indicated software for the diagnosis of Electrographic Status Epilepticus with U.S. Centers for Medicare and Medicaid Services approved New Technology Add-on Payment (NTAP).

This company page was created by Nurse Lydia. This listing is not currently maintained by, endorsed by or affiliated with Ceribell │ AI-Powered Point-of-Care EEG.

Only a current employee of Ceribell │ AI-Powered Point-of-Care EEG can claim this page. Know someone who can claim this page? Contact us